v3.25.3
SCHEDULE OF DEFERRED TAX ASSETS NET (Details) - USD ($)
Jul. 31, 2025
Jul. 31, 2024
Income Tax Disclosure [Abstract]    
Property and equipment $ 730 $ 731
Marketable Securities 11,760 15,678
Intellectual property 260,860 256,741
Warrant liability
Share issuance costs 310,230 376,978
Investment in BC Therapeutics 44,650 19,172
Operating tax losses carried forward 5,067,840 4,850,799
Operating tax losses carried forward- USA 8,494,300 5,545,125
Research and Development 14,240,640 10,879,373
Total deferred tax assets 28,431,010 21,944,597
Valuation allowance (24,329,720) (18,034,710)
Net deferred tax assets 4,101,290 3,909,887
Intellectual Property
Warrant liability (4,053,520) (3,848,762)
Property, plant, and equipment (47,770) (61,125)
Total net deferred tax liabilities (4,101,290) (3,909,887)
Valuation allowance
Net deferred tax assets (liabilities)